Patrick M. Forde
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
- Oncology 114
- Cancer Immunotherapy and Biomarkers 95
- Lung Cancer Research Studies 22
- CAR-T cell therapy research 13
-
- Lung Cancer Treatments and Mutations 49
- Lung Cancer Diagnosis and Treatment 23
- Occupational and environmental lung diseases 15
- Co-authors
- Julie R. Brahmer (75 shared papers)Jarushka Naidoo (38 shared papers)Evan J. Lipson (15 shared papers)David S. Ettinger (24 shared papers)Kristen A. Marrone (34 shared papers)Suzanne L. Topalian (8 shared papers)Ronan J. Kelly (15 shared papers)Leisha A. Emens (5 shared papers)
- Journals
- Journal of Clinical Oncology (41 papers)Journal of Thoracic Oncology (16 papers)Cancer Research (14 papers)Journal for ImmunoTherapy of Cancer (10 papers)The Oncologist (7 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Patrick M. Forde
182 papers receiving 6.0k citations
Patrick M. Forde's Hit Papers
Peers
Comparison fields: 5 of 116
- Oncology 3.3k
- Pulmonary and Respiratory Medicine 2.1k
- Immunology 991
- Cancer Research 501
- Genetics 271
Countries citing papers authored by Patrick M. Forde
This map shows the geographic impact of Patrick M. Forde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick M. Forde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick M. Forde more than expected).
Fields of papers citing papers by Patrick M. Forde
This network shows the impact of papers produced by Patrick M. Forde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick M. Forde. The network helps show where Patrick M. Forde may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick M. Forde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non–Small Cell Lung Cancer Hit paper breakdown → | 2020 | 334 |
| 2 | Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations Hit paper breakdown → | 2016 | 278 |
| 3 | Phase I/Ib Clinical Trial of Sabatolimab, an Anti–TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti–PD-1 Antibody, in Advanced Solid Tumors Hit paper breakdown → | 2021 | 271 |
| 4 | Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Hit paper breakdown → | 2017 | 249 |
| 5 | 2015 | 247 | |
| 6 | 2018 | 198 | |
| 7 | Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy Hit paper breakdown → | 2023 | 174 |
| 8 | 2012 | 161 | |
| 9 | 2019 | 145 | |
| 10 | Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges Hit paper breakdown → | 2023 | 114 |
| 11 | 2018 | 114 | |
| 12 | 2018 | 114 | |
| 13 | 2020 | 112 | |
| 14 | Neoadjuvant Chemoimmunotherapy for NSCLC Hit paper breakdown → | 2024 | 106 |
| 15 | 2017 | 106 | |
| 16 | 2018 | 105 | |
| 17 | 2019 | 97 | |
| 18 | 2021 | 94 | |
| 19 | 2019 | 89 | |
| 20 | 2014 | 88 |
About Patrick M. Forde
Patrick M. Forde is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Immunology, having authored 188 papers that have together received 6.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (95 papers), Lung Cancer Treatments and Mutations (49 papers), Cancer Genomics and Diagnostics (23 papers), Lung Cancer Diagnosis and Treatment (23 papers), Lung Cancer Research Studies (22 papers), Immunotherapy and Immune Responses (18 papers), Occupational and environmental lung diseases (15 papers) and CAR-T cell therapy research (13 papers). The work is most often cited by research in Oncology (3.3k citations), Pulmonary and Respiratory Medicine (2.1k citations), Immunology (991 citations), Cancer Research (501 citations) and Genetics (271 citations). Patrick M. Forde has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Julie R. Brahmer, Jarushka Naidoo, Evan J. Lipson, David S. Ettinger, Kristen A. Marrone, Suzanne L. Topalian, Ronan J. Kelly, Leisha A. Emens, Janis M. Taube and Christine L. Hann. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancer Research, Journal for ImmunoTherapy of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.